Association between Alzheimer's disease and Periodontitis

Keywords

Alzheimer’s Disease; Chronic Inflammation; Periodontitis.

Introduction

Alzheimer's disease (AD) is a neurological ailment that distresses millions of people globally and has a rate that is rising quickly with a growing expectation of life and a growing world population [1]. Despite decades of extensive research, it remains unknown how degenerative neurodisorders such as AD occur. The interest in developing alternative ways to prevent and/or cure AD is therefore expanding. A number of modifiable risk factors such as physical inactivity, mental disorders, hypertension, diabetes mellitus and obesity have been evaluated, for instances [2]. In addition, several data now demonstrate the significance of inflammation as an important pathogenic mediator for AD and cognitive decline, which shows that communication, also exists between the brain and peripheral immune systems.

Periodontal conditions are typical chronic multi-bacterial infections, which harm the supporting teeth and contribute to a significant inflammatory and bacterial load in the system [3]. The periodontopathic bacteria and the systemic inflammation they induce are the basis of the proposed linkage between periodontal and cardiovascular diseases [4, 5]. The dental and periodontal infections have mechanisms that can effect on the systemic balance of inflammatory mediators, while generating inflammation locally [6, 7]. The postulated relationship between periodontal diseases and many other ailments, such as diabetes, renal problems and low birth weight, is based on periodontal bacteria and their systemic inflammatory mechanisms [8-10].

A potential link between periodontal illness and Alzheimer's progression has recently been suggested, the relationship between both being 'inflammation.'

In the following section, we will discuss the periodontitis pathogenesis and the mechanims associated with the progression of Alzheimer’s.

Rapport among Periodontitis vs. Alzheimer’s disease

Over the last ten years, growing data shows that Alzheimer's disease has a microbial and inflammatory genesis with the identification in the brain of Alzheimer's patients of oral and air route bacterial communities, fungal and viruses [11]. In addition, ß-amyloid oligomeric species, known to have the cause of neuronal network disruption, have antimicrobial capabilities that reinforce the hypothesis that host microbiota communication might stay at the beginning of dementia.

Periodontitis, a tenacious inflammatory disorder, instigated by pathogenic bacteria, has remained connected to an augmented ß-amyloid load and mental infirmities far along in lifespan [12]. Periodontitis affects the gingivae, periodontal ligament and alveolar bone owing to chronic multifactorial inflammatory variations in the periodontal tissues as a consequence of the host reaction to periodontal bacterial communities. The periodontal pocket was colonized by over 400 bacteria and viruses. The utmost contagious bacterial groups incline to comprise Gram-negative bacteria proficient of tissue invasion.

They include Tanerella forsythia, Treponema denticola, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans [13]. Host reaction to periodontal pathogens can be exaggerated by gene polymorphisms, chiefly code for IL-1 and TNF-a. Additionally, the host reply is identified to be influenced by various daily life features, for model tobacco smoking and anxiety, which are equally connected with bigger threat of AD. Diet and other lifestyle features are assumed to distress gene expression.

Established on an impact of periodontitis to systemic inflammation and the probable involvement of inflammation in the etiology and development of AD, a hazard feature in occurrence and advancement of AD may be postulated as a chronic periodontitis [14]. The following elements can be seen as a connection between them. Although the brain is supposed to be immune-isolated, many reports demonstrated that systemic inflammation promotes neurodegenerations through activation and release of pro-inflammatory chemicals that lead to AD (Figure 1).

P. gingivalisa culprit in Alzheimer's disease

The supposed mechanism underlying this implication include: pathogen entrance through the trigeminal nerve, pathogen fudging into the bloodstream over the neo-vascularized inflamed tissue, low-grade chronic systemic inflammation, augmented penetrability of the blood–brain barrier (BBB), and microbial-induced amyloidogenesis. Although several studies have shown that P.gingivalis and/or its gingipain products are transferred to brains in a more modern work employing a model of periodontitis and human postmortem brain tissue from people with Alzheimer's disease [15].

Formerly, researchers had revealed that oral injection of P. gingivalis, for the period of 5 months for every 2 days interval is sufficient to activate the neuropathology with amyloidosis an Alzheimer’s disease-like, tauopathy, and neurodegeneration in the hippocampus and cortical regions [16]. Consequently, the presence of P. gingivalis in the frame possibly designates that acquaintance to the bacterial derivatives may outcome from brushing, flossing, and chewing triggering bleeding and bacteria evasion. Hence, periodontitis might upshot in recurring contact of distant organs such as the brain, liver, and pancreas to bacteria and their derivatives.

A modern study offers confirmation that gingipains along withP. gingivalis in the brain perform a vital part in the pathogenesis of Alzheimer’s disease and more validate the occurrence of P. gingivalis DNA, and gingipain antigens in the brain of Alzheimer’s disease infected individuals [17, 18]. Additional, this similareffortdisplayed that in vivo hypodermic and oral administration of small-molecule gingipain inhibitors or the broad spectrum antibiotic moxifloxacin restrict gingipain-induced neurodegeneration, suggestively decrease the P. gingivalis load in the brain of aged mice, and decrease the host Ab1–42 response to P. gingivalis brain infection, providing an captivating new outline for management of the disease [19, 20].

×

Figure 1:

Close

Figure 1. Figure represents the induction of AD with the progression of periodontal disease. Intensive production of inflammatory molecules including IL-1, IL-6, TNF-, and CRP illustrates the platform serves of AD pathogenesis. Periodontal disorders may have an adverse effect on AD development via bacterial invasion directly or indirectly via bacterial products (LPS) or host response molecules (cytokin, CRP). These chemicals will further strengthen the inflammatory signal by activating glial cells that have previously been primed and boost the formation of molecules such as the amyloid Peptide, P-taus, and finally start a degeneration route.

Conclusion

There is currently not sufficient data to establish a relationship between the two disorders, but the evidence available shows a good trend towards their correlation.With periodontitis and AD that demonstrate important links, dental management must be an intervention by all members of society from an early age as a prevention measures. A lot of research has justifiably concentrated on making periodontitis a recognized modifiable risk factor in the context of AD from the standpoint of periodontal microbiome.

Acknowledgement

This work is funded and supported by the seed money research projects grant aid by Vinayaka Mission’s Research Foundation – Deemed to be University, Salem, Tamilnadu , India ( ID – VMRF/ Seed Money/2020/VMMC-KKL/3).